Literature DB >> 23093319

Diagnosis and management of upper extremity deep-vein thrombosis in adults.

Jonathan D Grant1, Scott M Stevens, Scott C Woller, Edward W Lee, Stephen T Kee, David M Liu, Derek G Lohan, C Gregory Elliott.   

Abstract

Upper extremity deep-vein thrombosis (UEDVT) is common and can cause important complications, including pulmonary embolism and post-thrombotic syndrome. An increase in the use of central venous catheters, particularly peripherally inserted central catheters has been associated with an increasing rate of disease. Accurate diagnosis is essential to guide management, but there are limitations to the available evidence for available diagnostic tests. Anticoagulation is the mainstay of therapy, but interventional treatments may be considered in select situations. The risk of UEDVT may be reduced by more careful selection of patients who receive central venous catheters and by use of smaller catheters. Herein we review the diagnosis, management and prevention of UEDVT. Due to paucity of research, some principles are drawn from studies of lower extremity DVT. We present a practical approach to diagnosing the patient with suspected deep-vein thrombosis of the upper extremity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093319     DOI: 10.1160/TH12-05-0352

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  27 in total

Review 1.  Interventional Therapy for Upper Extremity Deep Vein Thrombosis.

Authors:  Timothy A Carlon; Deepak Sudheendra
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

2.  Incidence of upper-extremity deep vein thrombosis in western France: a community-based study.

Authors:  Aurélien Delluc; Raphaël Le Mao; Cécile Tromeur; Nathalie Chambry; Hélène Rault-Nagel; Luc Bressollette; Dominique Mottier; Francis Couturaud; Karine Lacut
Journal:  Haematologica       Date:  2018-08-03       Impact factor: 9.941

3.  Deep Vein Thrombosis of the Upper Extremity.

Authors:  Jan Heil; Wolfgang Miesbach; Thomas Vogl; Wolf O Bechstein; Alexander Reinisch
Journal:  Dtsch Arztebl Int       Date:  2017-04-07       Impact factor: 5.594

Review 4.  A systematic review of patient-related risk factors for catheter-related thrombosis.

Authors:  Amy Leung; Clare Heal; Marlon Perera; Casper Pretorius
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

5.  Retrosternal Reconstruction Can be a Risk Factor for Upper Extremity Deep Vein Thrombosis After Esophagectomy.

Authors:  Takamasa Takahashi; Masahide Fukaya; Kazushi Miyata; Yayoi Sakatoku; Masato Nagino
Journal:  World J Surg       Date:  2017-12       Impact factor: 3.352

Review 6.  Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.

Authors:  Nick van Es; Suzanne M Bleker; Ineke T Wilts; Ettore Porreca; Marcello Di Nisio
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

Review 7.  Guidance for the treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Michael B Streiff; Giancarlo Agnelli; Jean M Connors; Mark Crowther; Sabine Eichinger; Renato Lopes; Robert D McBane; Stephan Moll; Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

Review 8.  Venous thromboembolism in hematopoietic stem cell transplant recipients.

Authors:  S Chaturvedi; A Neff; A Nagler; U Savani; M Mohty; B N Savani
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

Review 9.  Upper extremity deep venous thrombosis and pulmonary embolus after ovarian hyperstimulation.

Authors:  Anne Catherine Miller Cramer; Anna Warszawa McLean; Jalil Ahari
Journal:  BMJ Case Rep       Date:  2016-08-16

10.  Incidence and clinical implications of upper extremity deep vein thrombosis after laparoscopic bariatric procedures.

Authors:  Fernando M Safdie; Fernando Dip; Jessica Ardila-Gatas; Savannah Moon; Emanuele Lo Menzo; Samuel Szomstein; Raul Rosenthal
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.